Skip to content

Management of Gout through Ayurveda

CLINICAL EVALUATION OF PUNARNAVA AMRITA GUGGULU IN THE MANAGEMENT OF VATA-RAKTA(GOUT)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/033171
Enrollment
40
Registered
2021-04-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E798- Other disorders of purine and pyrimidine metabolism

Interventions

Intervention1: Punarnava Amrita Guggulu: 2 Vati (Each Vati 500mg) Twice a day with luke warm water for 45 days Control Intervention1: NIL: NIL

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group of 20-60 years of either sex presenting with clinical features of Vata-rakta. Diagnosed and confirmed case of Vata-rakta (Gout). Patients having serum uric acid level more than 6 mg/dl with or without any associated features like joint pain and inflammation. Patients having any Metabolic disorder like Diabetes mellitus, Cardiac disease.

Exclusion criteria

Exclusion criteria: Patients below 20 years and above 60 years will be excluded. Patients suffering with other form of Arthritis like Rheumatoid arthritis, Osteoarthritis, Ankylosing spondylitis, Infective arthritis etc. Pregnant and lactating mother. Patients with evidence of malignancy.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective parameters like Sandhi Shoola, Sandhi Shotha,Vidaha,Raga, Toda,Twakvaivarnya ,Sparsha Asahyata,Visphota,Sandhi Akunchana, Prasarana Vedna Sandhi Vikriti and objective parameter CBC, ESR,Serum uric acid,Blood urea,Urine complete Fasting blood sugar (FBS), Radiological investigation - X-rays of affected joint Timepoint: At Baseline and 6 Weeks

Secondary

MeasureTime frame
Efficacy will be Assessed on the basis of improvement in Subjective and Objective ParametersTimepoint: At base line and 6 weeks

Countries

India

Contacts

Public ContactDr Divya Singh Charan

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026